Antisense technology involves the manipulation of DNA or RNA to inhibit the translation of mRNA into proteins by using complementary oligonucleotides. This approach has historical roots in the late 20th century and has applications across medical, veterinary, agricultural, and industrial fields, notably in cancer therapy and drug discovery. Recent advancements have improved the efficacy and safety of antisense oligonucleotides, making them promising tools for treating diseases related to abnormal protein production.